Stories

Cultural reportage
and personal essays.

Published intermittently. Always cultural, never prescriptive. Subscribe to the monthly letter to get the next one in your inbox.

All stories.

Analysis · Clinical data analysis

Retatrutide: the five numbers everyone is ignoring.

Everyone repeats 24%. I think it is the least interesting figure in the Phase 2 data — and the five that matter are what the TRIUMPH readouts will decide.

7 min read
Essay · New

The third way. A cultural letter on the year the body conversation changed.

For a century the equation had two terms: diet and exercise. Then a generation woke up and the sentence had a third. An essay on what that third sentence does to a culture.

9 min read
Cultural · Essay

The "Ozempic personality" — what the science actually says about mood and behavior.

The cultural phenomenon, the honest read on the neuroscience, and what it means for how we talk about pleasure and motivation in the medicated era.

13 min read
Reportage

The first pill. Notes on the year medication moved from the needle to the medicine cabinet.

What it means culturally that the next generation of weight-loss medication is a tablet. How the conversation shifts when the friction of injection disappears.

12 min read
Reportage

The next chapter has a name. Cultural notes on what arrives after the headlines.

Every wave of medication brings its own cultural ripples. A reportage on what is coming, what it means for the conversation, and the questions the data cannot answer.

12 min read
Reportage · Policy

Fourteen molecules, one regulatory pivot.

In February 2026, HHS moved 14 previously restricted molecules back toward legal compounding access. The cultural and political backdrop of a quiet rule change.

9 min read

One thoughtful letter, once a month.

The cultural essays, the reading recommendations, the conversation behind the next piece. First Sunday of every month.

Subscribe to the letter